• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 SEER 数据库的原发性肺肉瘤预后预测模型研究。

Prognostic visualization model for primary pulmonary sarcoma: a SEER-based study.

机构信息

Sichuan North Medical College, Nanchong, 637000, Sichuan Province, China.

Zigong First People's Hospital, Zigong City, 643000, Sichuan Province, China.

出版信息

Sci Rep. 2023 Oct 18;13(1):17774. doi: 10.1038/s41598-023-45058-7.

DOI:10.1038/s41598-023-45058-7
PMID:37853232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10584923/
Abstract

Primary pulmonary sarcoma (PPS) is a rare and poor prognostic malignancy that results from current clinical studies are lacking. Our study aimed to investigate the prognostic factors of PPS and to construct a predictive nomogram that predict the overall survival (OS) rate. We extracted data on patients diagnosed with PPS from 2010 to 2019 in the SEER database. A total of 169 patients were included after screening by inclusion and exclusion criteria. Univariate and multivariate COX regression analyses showed that age, pathological grade, liver metastasis, surgical intervention, and chemotherapy influenced the prognosis. We constructed the prediction model nomogram based on these factors. Moreover, the results of the internal and external ROC curves, calibration curves, and DCA plots confirmed that the model has good discrimination, accuracy, and clinical practice efficacy. The present study is the first population-based study to explore the factors affecting the prognosis of PPS. We established a novel prognostic nomogram to predict the OS rate, which can help to make proper clinical decisions.

摘要

原发性肺肉瘤(PPS)是一种罕见的预后不良的恶性肿瘤,目前缺乏临床研究结果。本研究旨在探讨 PPS 的预后因素,并构建一个预测总生存率(OS)的列线图。我们从 SEER 数据库中提取了 2010 年至 2019 年诊断为 PPS 的患者数据。经过纳入和排除标准筛选后,共纳入 169 例患者。单因素和多因素 COX 回归分析显示,年龄、病理分级、肝转移、手术干预和化疗影响预后。我们基于这些因素构建了预测模型列线图。此外,内部和外部 ROC 曲线、校准曲线和 DCA 图的结果证实,该模型具有良好的区分度、准确性和临床实践效果。本研究是首个基于人群的研究,探讨了影响 PPS 预后的因素。我们建立了一个新的预后列线图来预测 OS 率,这有助于做出适当的临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/ae18d1a5f58a/41598_2023_45058_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/470f95912157/41598_2023_45058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/62ec451456cc/41598_2023_45058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/ed87398e586d/41598_2023_45058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/6f3328a88f3a/41598_2023_45058_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/6a7c7ad327ec/41598_2023_45058_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/73d0dc7036bd/41598_2023_45058_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/ae18d1a5f58a/41598_2023_45058_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/470f95912157/41598_2023_45058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/62ec451456cc/41598_2023_45058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/ed87398e586d/41598_2023_45058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/6f3328a88f3a/41598_2023_45058_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/6a7c7ad327ec/41598_2023_45058_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/73d0dc7036bd/41598_2023_45058_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de5d/10584923/ae18d1a5f58a/41598_2023_45058_Fig7_HTML.jpg

相似文献

1
Prognostic visualization model for primary pulmonary sarcoma: a SEER-based study.基于 SEER 数据库的原发性肺肉瘤预后预测模型研究。
Sci Rep. 2023 Oct 18;13(1):17774. doi: 10.1038/s41598-023-45058-7.
2
SEER-Based Survival Nomogram (1998-2015) Based on 'Stage, Lymph Node Dissection, Tumor Size and Degree of Differentiation, and Therapies' for Prognosis of Primary Pulmonary Sarcoma.基于“分期、淋巴结清扫、肿瘤大小和分化程度以及治疗”的 SEER 生存列线图(1998-2015 年)用于原发性肺肉瘤的预后评估。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338221150732. doi: 10.1177/15330338221150732.
3
Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.基于 SEER 的回顾性研究:开发和验证用于预测原发性膀胱肉瘤患者总生存期的预后列线图。
BMC Urol. 2021 Nov 25;21(1):162. doi: 10.1186/s12894-021-00929-x.
4
Development and validation of a prognostic nomogram for adult patients with renal sarcoma: A retrospective study based on the SEER database.基于 SEER 数据库的回顾性研究:建立和验证用于预测成人肾肉瘤患者预后的列线图
Front Public Health. 2022 Sep 12;10:942608. doi: 10.3389/fpubh.2022.942608. eCollection 2022.
5
The clinical characteristics, novel predictive tool, and risk classification system for primary Ewing sarcoma patients that underwent chemotherapy: A large population-based retrospective cohort study.基于大人群回顾性队列研究的原发性尤文肉瘤患者接受化疗的临床特征、新型预测工具和风险分类系统。
Cancer Med. 2023 Mar;12(5):6244-6259. doi: 10.1002/cam4.5379. Epub 2022 Oct 21.
6
Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic Cancer: A Population-Based Analysis.列线图预测胰腺癌骨转移的风险和预后因素:基于人群的分析。
Front Endocrinol (Lausanne). 2022 Mar 9;12:752176. doi: 10.3389/fendo.2021.752176. eCollection 2021.
7
Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.化疗治疗小细胞肺癌患者总生存预后列线图:基于 SEER 的回顾性队列研究。
Adv Ther. 2022 Jan;39(1):346-359. doi: 10.1007/s12325-021-01974-6. Epub 2021 Nov 3.
8
Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study.两种预测肺转移胰腺癌患者风险和预后的新型列线图:基于人群的研究。
Front Public Health. 2022 May 31;10:884349. doi: 10.3389/fpubh.2022.884349. eCollection 2022.
9
Development and Validation of Novel Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Patients With Soft Tissue Sarcoma.软组织肉瘤患者特定远处转移部位和总生存的新型列线图的建立和验证。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821997828. doi: 10.1177/1533033821997828.
10
A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.基于 SEER 的列线图能准确预测尤文肉瘤的预后。
Sci Rep. 2021 Nov 22;11(1):22723. doi: 10.1038/s41598-021-02134-0.

引用本文的文献

1
Outcomes and prognostic factors in primary intrathoracic soft tissue sarcoma.原发性胸内软组织肉瘤的治疗结果及预后因素
J Thorac Dis. 2025 Aug 31;17(8):5499-5508. doi: 10.21037/jtd-2025-582. Epub 2025 Aug 21.
2
Durable Disease Control in Primary Pulmonary Sarcomatoid Carcinoma Following Pneumonectomy.肺切除术后原发性肺肉瘤样癌的持久疾病控制
Diagnostics (Basel). 2025 Jul 5;15(13):1718. doi: 10.3390/diagnostics15131718.

本文引用的文献

1
Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study.辅助化疗并非改善肺肉瘤总体生存率的决定性因素:一项基于人群的研究。
Front Oncol. 2022 Aug 25;12:940839. doi: 10.3389/fonc.2022.940839. eCollection 2022.
2
Role of radiation therapy in primary tonsil large B cell lymphoma: a SEER-based analysis.放疗在扁桃体原发弥漫性大 B 细胞淋巴瘤中的作用:基于 SEER 的分析。
Radiat Oncol. 2021 Oct 2;16(1):193. doi: 10.1186/s13014-021-01919-x.
3
Outcomes of surgically managed primary lung sarcomas: a National Cancer Database analysis.
手术治疗原发性肺肉瘤的结果:一项国家癌症数据库分析。
J Thorac Dis. 2021 Jun;13(6):3409-3419. doi: 10.21037/jtd-21-1.
4
Results of treating primary pulmonary sarcomas and pulmonary carcinosarcomas.原发性肺肉瘤和肺癌肉瘤的治疗结果。
J Thorac Cardiovasc Surg. 2021 Jul;162(1):274-284. doi: 10.1016/j.jtcvs.2020.03.179. Epub 2020 Jun 17.
5
Multimodality treatment including surgery for primary pulmonary sarcoma: Size does matter.多模态治疗包括原发性肺肉瘤的手术:大小很重要。
J Surg Oncol. 2020 Sep;122(3):506-514. doi: 10.1002/jso.25979. Epub 2020 May 14.
6
Commentary: Primary pulmonary sarcomas and pulmonary carcinosarcomas, challenging and enigmatic, but treatable!述评:原发性肺肉瘤和肺癌肉瘤,具有挑战性且神秘莫测,但可治疗!
J Thorac Cardiovasc Surg. 2021 Jul;162(1):286-287. doi: 10.1016/j.jtcvs.2020.03.138. Epub 2020 Apr 11.
7
Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma.美司钠、多柔比星、异环磷酰胺和达卡巴嗪(MAID)治疗晚期肺多形性癌的疗效。
Lung Cancer. 2018 Aug;122:160-164. doi: 10.1016/j.lungcan.2018.06.009. Epub 2018 Jun 9.
8
Clinical features and surgical outcomes of pulmonary artery sarcoma.肺动脉肉瘤的临床特征和手术治疗效果。
J Thorac Cardiovasc Surg. 2018 Mar;155(3):1109-1115.e1. doi: 10.1016/j.jtcvs.2017.10.101. Epub 2017 Nov 10.
9
Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report.立体定向消融放疗治疗原发性肺肉瘤:一例报告
Onco Targets Ther. 2017 Jul 4;10:3285-3288. doi: 10.2147/OTT.S138595. eCollection 2017.
10
Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base.肺肉瘤样癌:国家癌症数据库分析
Clin Lung Cancer. 2017 May;18(3):286-292. doi: 10.1016/j.cllc.2016.11.016. Epub 2016 Dec 7.